Stephen T Zarrilli
Insider
First SEC filing: March 7, 2024 · Latest: March 7, 2024
Insider at
Insider transactions
0 buys (P)
2 sells (S)
Net: $-4,283,250
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 18, 2026 | GMED | M | 25,000 | $53.27 | $1,331,750 | 25,000 Direct | · | Acquired | 43.7% (price as of 2026-10-05) |
| Aug. 18, 2026 | GMED | S | 25,000 | $87.04 | $2,176,000 | 0 Direct | -100.00% | Disposed | -12.0% (price as of 2026-10-05) |
| Aug. 18, 2026 | GMED | M | 25,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Jan. 21, 2026 | GMED | A | 15,000 | · | · | 15,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Nov. 11, 2025 | GMED | M | 25,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Nov. 11, 2025 | GMED | S | 25,000 | $84.29 | $2,107,250 | 0 Direct | -100.00% | Disposed | -9.2% (price as of 2026-10-05) |
| Nov. 11, 2025 | GMED | M | 25,000 | $44.14 | $1,103,500 | 25,000 Direct | · | Acquired | 73.5% (price as of 2026-10-05) |
| Jan. 23, 2025 | GMED | A | 15,000 | · | · | 15,000 Direct | · | Acquired | (price as of 2026-10-05) |
| March 6, 2024 | VRTS | S | 2,150 | $248.40 | $534,060 | 3,549 Direct | -37.73% | Disposed | -45.9% (price as of 2026-10-05) |
| Jan. 26, 2024 | GMED | A | 15,000 | · | · | 15,000 Direct | · | Acquired | (price as of 2026-10-05) |
| May 17, 2023 | VRTS | A | 602 | $178.54 | $107,481 | 5,699 Direct | +11.81% | Acquired | -24.7% (price as of 2026-10-05) |
| Jan. 26, 2023 | GMED | A | 15,000 | · | · | 15,000 Direct | · | Acquired | (price as of 2026-10-05) |
| May 18, 2022 | VRTS | A | 585 | $175.00 | $102,375 | 5,097 Direct | +12.97% | Acquired | -23.2% (price as of 2026-10-05) |
| Jan. 27, 2022 | GMED | A | 15,000 | · | · | 15,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 3, 2021 | VRTS | S | 1,808 | $280.55 | $507,234 | 4,512 Direct | -28.61% | Disposed | -52.1% (price as of 2026-10-05) |
| May 14, 2021 | VRTS | A | 367 | $268.04 | $98,371 | 6,320 Direct | +6.16% | Acquired | -49.8% (price as of 2026-10-05) |
| Jan. 14, 2021 | GMED | A | 15,000 | · | · | 15,000 Direct | · | Acquired | (price as of 2026-10-05) |
| May 18, 2020 | VRTS | A | 1,138 | $89.16 | $101,464 | 5,953 Direct | +23.63% | Acquired | 50.8% (price as of 2026-10-05) |
| Jan. 22, 2020 | GMED | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-05) |
| May 15, 2019 | VRTS | A | 902 | $117.78 | $106,238 | 4,815 Direct | +23.05% | Acquired | 14.2% (price as of 2026-10-05) |
| May 1, 2019 | GMED | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-05) |
| May 15, 2018 | VRTS | A | 856 | $124.00 | $106,144 | 3,913 Direct | +28.00% | Acquired | 8.4% (price as of 2026-10-05) |
| May 19, 2017 | VRTS | A | 976 | $103.70 | $101,211 | 3,057 Direct | +46.90% | Acquired | 29.7% (price as of 2026-10-05) |
| May 25, 2016 | VRTS | A | 1,129 | $80.81 | $91,234 | 2,081 Direct | +118.59% | Acquired | 66.4% (price as of 2026-10-05) |
| May 28, 2015 | VRTS | A | 648 | $127.25 | $82,458 | 952 Direct | +213.16% | Acquired | 5.7% (price as of 2026-10-05) |
| Oct. 8, 2014 | VRTS | A | 304 | $169.72 | $51,595 | 304 Direct | · | Acquired | -20.8% (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 18, 2026 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.27 | Jan. 22, 2030 | 25,000 | Disposed |
| Jan. 21, 2026 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $94.15 | Jan. 21, 2036 | 15,000 | Acquired |
| Nov. 11, 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $44.14 | May 1, 2029 | 25,000 | Disposed |
| Jan. 23, 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $92.42 | Jan. 23, 2035 | 15,000 | Acquired |
| Jan. 26, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.75 | Jan. 26, 2034 | 15,000 | Acquired |
| Jan. 26, 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $75.18 | Jan. 26, 2033 | 15,000 | Acquired |
| Jan. 27, 2022 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $63.68 | Jan. 27, 2032 | 15,000 | Acquired |
| Jan. 14, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $65.05 | Jan. 14, 2031 | 15,000 | Acquired |
| Jan. 22, 2020 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.27 | Jan. 22, 2030 | 25,000 | Acquired |
| May 1, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $44.14 | May 1, 2029 | 25,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 3, 2019 | GMED | No securities are beneficially owned | 0 | Direct |